MTSR - SA Asks: What's the best weight-loss drug stock right now?
2025-04-17 16:11:00 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results
- Wall Street Lunch: Obesity Pill Progress
- Eli Lilly: Still Great, But Still Too Expensive Even As Earnings Near
- Why did Lilly data for oral GLP-1 boost Structure and Metsera?
- Biggest stock movers Thursday: TSM, LLY, UNH, and more